Circulating IGF-1 and SirT1 have both been implicatedin the protection against cardiac hypertrophy [10,17],although the role of IGF-1 and/or its isoforms in this process remainscontroversial [6,9-11]. Here, IGF1 is linked to cardiac hypertrophy.